CA Patent

CA2830742C — Substituted oxanes as opioid receptor ligands and methods of using and making same

Assigned to Trevena Inc · Expires 2023-03-14 · 3y expired

What this patent protects

This application relates to compounds that can act as opioid receptor ligands, which compounds can be used in the treatment of, for example, pain and pain related disorders. In one embodiment, there is provided a cornpound having a formula of , or a pharmaceutically acceptable sa…

USPTO Abstract

This application relates to compounds that can act as opioid receptor ligands, which compounds can be used in the treatment of, for example, pain and pain related disorders. In one embodiment, there is provided a cornpound having a formula of , or a pharmaceutically acceptable salt thereof. wherein: R21 and R22 are independently H or CH3; Di is an optionally substituted aryl or an optionally substituted heteroaryl; B3 is 1-1 or optionally substituted alkyl; and B5 is an optionally substituted thiophenyl.

Drugs covered by this patent

Patent Metadata

Patent number
CA2830742C
Jurisdiction
CA
Classification
—
Expires
2023-03-14
Drug substance claim
No
Drug product claim
No
Assignee
Trevena Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.